Oleuropein aglycone induces autophagy via the AMPK/mTOR signalling pathway: A mechanistic insight

Oncotarget

Volumn 6, Issue 34, 2015, Pages 35344-35357

  Rigacci, Stefania ^a   Miceli, Caterina ^a   Nediani, Chiara ^a   Berti, Andrea ^a   Cascella, Roberta ^a   Pantano, Daniela ^b   Nardiello, Pamela ^b   Luccarini, Ilaria ^b   Casamenti, Fiorella ^b   Stefani, Massimo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

AMPK; Autophagy; Gerotarget; MTOR; Neurodegeneration; Oleuropein aglycone

Indexed keywords

AMYLOID BETA PROTEIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE BETA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MAMMALIAN TARGET OF RAPAMYCIN; OLEUROPEIN AGLYCONE; POLYPHENOL; S6 KINASE; UNCLASSIFIED DRUG; IRIDOID; MTOR PROTEIN, HUMAN; OLEUROPEIN; TARGET OF RAPAMYCIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGY; CALCIUM CELL LEVEL; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; SIGNAL TRANSDUCTION; ANIMAL; DISEASE MODEL; DRUG EFFECTS; GENETICS; METABOLISM;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; AUTOPHAGY; DISEASE MODELS, ANIMAL; HUMANS; IRIDOIDS; MICE; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84946866919     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.6119     Document Type: Article

References (40)

1. Del Rio D, Rodriguez-Mateos A, Spencer J, Tognolini M, Borges G, Crozier A. Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal. 2013; 18:1818-1892.
2. Rodrigo R, Libuy M, Feliu F, Hasson D. Polyphenols in disease: from diet to supplements. Curr. Pharm. Biotechnol. 2014; 15 304-317.
3. Stefani M, Rigacci S. Beneficial properties of natural phenols: highlight on protection against pathological conditions associated with amyloid aggregation. Biofactors. 2014; 40 482-493.
4. Kim H, Montana V, Jang H, Parpura V, Kim J. Epigallocatechin gallate (EGCG) stimulates autophagy in vascular endothelial cells: a potential role for reducing lipid accumulation. J Biol Chem. 2013; 288:22693-22705.
5. Vingtdeux V, Giliberto L, Zhao H, Chandakkar P, Wu Q, Simon J, Janle E, Lobo J, Ferruzzi M, Davies P, Marambaud P. AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism. J Biol Chem. 2010; 285:9100-9113.
6. Zhou J, Farah B, Sinha R, Wu Y, Singh B, Bay B, Yang C, Yen P. Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, stimulates hepatic autophagy and lipid clearance. PLoS One. 2014; 29:e87161.
7. Lamb C, Yoshimori T, Tooze S. The autophagosome: origins unknown, biogenesis complex. Nat Rev Mol Cell Biol. 2013; 14 759-774.
8. Pallauf K, Rimbach G. The autophagosome: origins unknown, biogenesis complex. Ageing Res Rev. 2013; 12:237-252.
9. Cuervo A. Autophagy and aging: keeping that old broom working. Trends Genet. 2008; 24:604-612.
10. Bovè J, Martinez-Vicente M, Mila V. Fighting neurodegeration with rapamycin: mechanistic insight. Nat Rev Neurosci. 2011; 12:437-452.
11. Williams A, Sarkar S, Cuddon P, Ttofi E, Saiki S, Siddiqi F, Jahreiss L, Fleming A, Pask D, Goldsmith P, O'Kane C, Floto R, Rubinsztein D. Novel targets for Huntington's disease in an mTOR-independent autophagy pathway. Nat Chem Biol. 2008; 4:295-305.
12. Li Y, Chen C, Yao F, Su Q, Liu D, Xue R, Dai G, Fang R, Zeng J, Chen Y, Huang H, Ma Y, Li W, Zhang L, Liu C, Dong Y. AMPK inhibits cardiac hypertrophy by promoting autophagy via mTORC1. Arch Biochem Biophys. 2014; 558:79-86.
13. Mizushima N, Levine B, Cuervo A, Klionsky D. Autophagy fights disease through cellular self-digestion. Nature. 2008; 451:1069-75.
14. Rubinsztein D, Mariño G, Kroemer G. Autophagy and aging. Cell Cycle. 2011; 46:682-695.
15. Caccamo A, Maldonado M, Majumder S, Medina D, Holbein W, Magrí A, Oddo S. Naturally secreted amyloidbeta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism. J Biol Chem. 2011; 286:8924-8932.
16. Ravikumar B, Vacher C, Berger Z, Davies J, Luo S, Oroz L, Scaravilli F, Easton D, Duden R, O'Kane C, Rubinsztein D. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet. 2004; 36:585-595
17. Martin D, Ladha S, Ehrnhoefer D, Hayden M.: Autophagy in Huntington disease and huntingtin in autophagy. Trends Neurosci. 2015; 38:26-35.
18. Kabuta T, Suzuki Y, Wada K. Degradation of amyotrophic lateral sclerosis-linked mutant Cu, Zn-superoxide dismutase proteins by macroautophagy and the proteasome. J Biol Chem. 2006; 281:30524-30533.
19. Rigacci S, Guidotti V, Bucciantini M, Parri M, Nediani C, Cerbai E, Stefani M, Berti A. Oleuropein aglycon prevents cytotoxic amyloid aggregation of human amylin. J Nutr Biochem. 2010; 21:726-735.
20. Rigacci S, Guidotti V, Bucciantini M, Nichino D, Relini A, Berti A, Stefani M. A β(1-42) aggregates into nontoxic amyloid assemblies in the presence of the natural polyphenol oleuropein aglycon. Curr Alzheimer Res. 2011; 8:841-852.
21. Luccarini I, Grossi C, Rigacci S, Coppi E, Pugliese A, Pantano D, la Marca G, Ed Dami T, Berti A, Stefani M, Casamenti F. Oleuropein aglycone protects against pyroglutamylated-3 amyloid-β toxicity: biochemical, epigenetic and functional correlates. Neurobiol Aging. 2015; 36:648-663.
22. Casamenti F, Grossi C, Rigacci S, Pantano D, Luccarini I, Stefani M: Oleuropein Aglycone. A Possible Drug against Degenerative Conditions. In Vivo Evidence of its Effectiveness against Alzheimer's Disease. J Alzheimers Dis. 2015; 45:679-88.
23. Grossi C, Rigacci S, Ambrosini S, Ed Dami T, Luccarini I, Traini C, Failli P, Berti A, Casamenti F, Stefani M. The polyphenol oleuropein aglycone protects TgCRND8 mice against Aβ plaque pathology. PLoS One. 2013;8:e71702.
24. Bhullar K, Rupasinghe H. Polyphenols: multipotent therapeutic agents in neurodegenerative diseases. Oxid Med Cell Longev. 2013;2013:891748.
25. Kim H, Quon M, Kim J. New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate. Redox Biol. 2014; 2:187-195.
26. Marquez R, Xu L. Bcl-2:Beclin 1 complex: multiple, mechanisms regulating autophagy/apoptosis toggle switch. Am J Cancer Res. 2012; 2:214-221.
27. Vucicevic L, Misirkic M, Janjetovic K, Vilimanovich U, Sudar E, Isenovic E, Prica M, Harhaji-Trajkovic L, Kravic-Stevovic T, Bumbasirevic V, Trajkovic V. Compound C induces protective autophagy in cancer cells through AMPK inhibition-independent blockade of Akt/mTOR pathway. Autophagy. 2011; 7:40-50.
28. Liu X, Chipa R, Nakano I, Dasgupta B. The AMPK inhibitor compound C is a potent AMPK-independent antiglioma agent. Mol Cancer Ther. 2014;13:596-605.
29. Rigacci S, Stefani M.: Nutraceuticals and amyloid neurodegenerative diseases: a focus on natural phenols. Expert Rev Neurother 2015;15:41-52.
30. Sarkar S, Ravikumar B, Floto R, Rubinsztein D: Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies. Cell Death Differ. 2009; 16:46-56.
31. Alayev A, Doubleday P, Berger S, Ballif B, Holz M. Phosphoproteomics reveals resveratrol-dependent inhibition of Akt/mTORC1/S6K1 signaling. J Proteome Res. 2014;13: 5734-5742.
32. Choi Y, Suh H, Yoon Y, Lee K, Kim D, Kim S, Lee B. Protective effect of resveratrol derivatives on high-fat diet induced fatty liver by activating AMP-activated protein kinase. Arch Pharm Res. 2014; 37:1169-1176.
33. Wang L, Wang Y, Cui M, Luo W, Wang X, Barber P, ZY C. A dietary polyphenol resveratrol acts to provide neuroprotection in recurrent stroke models by regulating AMPK and SIRT1 signaling, thereby reducing energy requirements during ischemia. Eur J Neurosci. 2013; 37:1669-1681.
34. Quirantes-Piné R, Zurek G, Barrajón-Catalán E, Bäßmann C, Micol V, Segura-Carretero A, Fernández-Gutiérrez A. A metabolite-profiling approach to assess the uptake and metabolism of phenolic compounds from olive leaves in SKBR3 cells by HPLC-ESI-QTOF-MS. J Pharm Biomed Anal. 2013; 72:121-126.
35. Henning S, Wang P, Carpenter C, Heber D Epigenetic effects of green tea polyphenols in cancer. Epigenomics. 2013; 5(6):729-741.
36. Medina DL, Di Paola S, Peluso I, Armani A, De Stefani D, Venditti R, Montefusco S, Scotto-Rosato A, Prezioso C, Forrester A, Settembre C, Wang W, Gao Q, Xu H, Sandri M, Rizzuto R, De Matteis MA, A B. Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB. Nat Cell Biol. 2015; 17:288-299.
37. Codogno P MA. Autophagy: a potential link between obesity and insulin resistance. Cell Metab. 2010; 11:449-451.
38. Yang L, Li P, Fu S, Calay ES, GS H. Defective Hepatic Autophagy in Obesity Promotes ER Stress and Causes Insulin Resistance. Cell Metab. 2010; 11:467-478.
39. Liu HY, Han J, Cao SY, Hong T, Zhuo D, Shi J, Liu Z, W C. Hepatic autophagy is suppressed in the presence of insulin resistance and hyperinsulinemia: inhibition of FoxO1-dependent expression of key autophagy genes by insulin. J Biol Chem. 2009; 284:31484-31492.
40. Chishti M, Yang D, Janus C, Phinney A, Horne P, Pearson J, Strome R, Zuker N, Loukides J, French J, Turner S, Lozza G, Grilli M, Kunick iS, Morissette C, Paquette J, Gervais F, Bergeron C, Fraser P, Carlson G, George-Hyslop P, Westaway D. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem. 2001; 276: 21562-21570.